The modulation of alkylating agents
Frei, E.
Seminars in Hematology 28(3 Suppl 4: 22-24
1991
ISSN/ISBN: 0037-1963 PMID: 1664143 Document Number: 387003
Document emailed within 1 workday
Related Documents
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Bignold, L.P. 2006: Alkylating agents and DNA polymerases Anticancer Research 26(2b): 1327-1336
Lind, M.J.; Ardiet, C. 1993: Pharmacokinetics of alkylating agents Cancer Surveys 17: 157-188
Iamshanov, V.A.; Kraĭz, B.O.; Petrov, A.S. 1973: Interaction of DNA with alkylating agents of different classes Voprosy Onkologii 19(2): 60-62
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Schmähl, D. 1986: Carcinogenicity of anticancer drugs and especially alkylating agents Iarc Scientific Publications 78: 29-35
Lisker, S.A. 1970: Chemotherapy for malignant disease: the alkylating agents Delaware Medical Journal 42(5): 127-130
Canellos, G.P. 1989: The role of alkylating agents in acute and chronic leukemia Bone Marrow Transplantation 4(Suppl 1): 46-47
Wheeler, G.P. 1973: Recent advances in the biochemical pharmacology of selected alkylating agents Transplantation Proceedings 5(3): 1167-1170
Romanova, I.N. 1972: Effect of alkylating agents on the ATPase activity of liver mitochondria Biokhimiia 37(4): 846-850
Mittelman, A.; Catane, R.; Murphy, G.P. 1977: New steroidal alkylating agents in advanced stage D carcinoma of the prostate Cancer Treatment Reports 61(2): 307-310
Machoń, Z. 1975: Advances made in the chemistry of alkylating agents and treatment of cancer Postepy Higieny i Medycyny Doswiadczalnej 29(4): 443-472
Veremko, L.N.; Telegin, L.I.; Pevnitskii, L.A. 1983: Variability of the sensitivity of human lymphocytes to the antiproliferative action of alkylating agents Biulleten' Eksperimental'noi Biologii i Meditsiny 95(5): 73-75
Buckner, J.C.; Moynihan, T.J. 2001: The DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents New England Journal of Medicine 344(9): 686; Author Reply 687-688
Zwierzina, H.; Loidl, A.; Fuith, L.C.; Helliger, W.; Puschendorf, B.; Grunicke, H. 1984: Depression of histone acetylation by alkylating antitumor agents in murine cells Cancer Research 44(8): 3336-3339
Lomova, T.I.; Shakhova, I.K.; Shkodinskaia, E.N. 1981: Repair of DNA-protein cross-links induced by antineoplastic alkylating agents Biulleten' Eksperimental'noi Biologii i Meditsiny 92(7): 74-76
Botnick, L.E.; Hannon, E.C.; Hellman, S. 1978: Multisystem stem cell failure after apparent recovery from alkylating agents Cancer Research 38(7): 1942-1947
Farmer, P.B.; Bailey, E.; Green, J.A.; Leung, C.S.; Manson, M.M. 1991: Biomonitoring of human exposure to alkylating agents by measurement of adducts to haemoglobin or DNA Iarc Scientific Publications 105: 71-77
Ebert, R.; Bleichert, J. 1987: Suitability of mercapturic acid determination for biological monitoring of electrophilic alkylating agents Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 33(8): 373-374